Cargando…
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
Hepatocellular carcinoma (HCC) is disease with a high mortality rate and limited treatment options. Alterations of fibroblast growth factor receptor 4 (FGFR4) has been regarded as an oncogenic driver for HCC and a promising target for HCC therapeutics. Herein, we report that GNF-7, a multi-targeted...
Autores principales: | Nam, Yunju, Shin, Injae, Kim, Younghoon, Ryu, SeongShick, Kim, Namdoo, Ju, Eunhye, Sim, Taebo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649585/ https://www.ncbi.nlm.nih.gov/pubmed/34864570 http://dx.doi.org/10.1016/j.neo.2021.11.011 |
Ejemplares similares
-
Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance
por: Kim, Namkyoung, et al.
Publicado: (2021) -
Novel Small Molecules Capable of Blocking mtRAS-Signaling Pathway
por: Kim, Namkyoung, et al.
Publicado: (2021) -
Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance
por: Nam, Yunju, et al.
Publicado: (2022) -
Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors
por: Nam, Yunju, et al.
Publicado: (2019) -
In Silico Molecular Docking and In Vitro Antidiabetic Studies of Dihydropyrimido[4,5-a]acridin-2-amines
por: Bharathi, A., et al.
Publicado: (2014)